Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
Buses began moving thousands of global Scouts from their campsite on South Korea’s coast to inland venues ahead of a tropical storm that is forecast to bring intense rains and strong winds to the peninsula.
